Chronic PainNCT05933564
Cognitive Reserve on Pain Catastrophizing and Cognitive Function in Geriatric Patients With Chronic Pain
An observational study of Chronic Pain, run by Ahram Canadian University at 1 site in Egypt.
Trial summary
To investigate the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain, and to explore whether cognitive reserve moderates the relationship between pain catastrophizing and cognitive function. Read more about this study
- Who is it for?
- Ages 65 to 85 years
- Conditions the study is for
- Chronic Pain
- How many people
- 110 participants
- Where
- 1 siteEgypt
- Study dates
- 30 Jun 2023to 30 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 to 85 years
- All sexes
- No healthy volunteers
- Older adult
Study population: The study population consists of community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions.
Who may be able to join
- Aged 65 to 85 years
- Experiencing chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions
- Able to read, write, and speak the language in which assessments are administered
- Willing and able to provide informed consent
Who cannot join
- Diagnosed with a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease)
- History of significant head injury, stroke, or brain tumor
- Current substance abuse or dependence
- Severe psychiatric illness (e.g., schizophrenia, bipolar disorder)
- Significant sensory or motor impairments that may interfere with the ability to complete assessments
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, 3221405
Mohamed M ElMeligie, Ph.d, 01064442032, mohamed.elmeligie@acu.edu.eg
About this study
Official title: The Association Between Cognitive Reserve, Pain Catastrophizing, and Cognitive Function in Geriatric Patients With Chronic Pain: A Cross-sectional Study
To investigate the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain, and to explore whether cognitive reserve moderates the relationship between pain catastrophizing and cognitive function.
- Conditions
- Chronic Pain
- Being tested
- No intervention (cross-sectional study)
- Medical subject headings
- Chronic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention (cross-sectional study)Other
This is a cross-sectional study examining the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain; no intervention is being implemented or tested.
| Study group | Role | What they receive |
|---|---|---|
| Chronic Pain Patients with Varying Cognitive Reserve | Community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions. Receives: Other: No intervention (cross-sectional study) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Association between pain catastrophizing and cognitive function
he relationship between pain catastrophizing, as measured by the Pain Catastrophizing Scale (PCS), and cognitive function, as measured by the Montreal Cognitive Assessment (MoCA version 7.1).
Measured: Baseline assessment
Secondary outcomes (1)
Moderating effect of cognitive reserve on the association between pain catastrophizing and cognitive function
Investigate whether cognitive reserve, as measured by the Cognitive Reserve Index Questionnaire (CRIq), moderates the relationship between pain catastrophizing (PCS) and cognitive function (MoCA version 7.1).
Measured: Baseline assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jul 2023
- Study start30 Jun 2023 (estimated)
- Primary completion30 Dec 2023 (estimated)
- Study completion30 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Family based
- Time perspective
- Cross-sectional
- Enrolment
- 110 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ahram Canadian University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Magdy ElMeligie, Ahram Canadian University
- Investigators
- Amal Fawzy, Ph.d, Study director, Faculty of Physical Therapy, Ahram Canadian University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05933564
- Sponsor's protocol ID
- 012/20265888
- Status last verified
- Jun 2023
- First submitted
- 28 Jun 2023
- Last updated
- 6 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Association Between Cognitive Reserve, Pain Catastrophizing, and Cognitive Function in Geriatric Patients With Chronic Pain: A Cross-sectional Study
- ClinicalTrials.gov ID
- NCT05933564
- Acronym / sponsor ID
- 012/20265888
- Conditions
- Chronic Pain
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 110 participants (estimated)
- Lead sponsor
- Ahram Canadian UniversityUniversity, hospital or other
- Study start
- 30 Jun 2023 (estimated)
- Primary completion
- 30 Dec 2023 (estimated)
- Study completion
- 30 Dec 2023 (estimated)
- First posted
- 6 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To investigate the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain, and to explore whether cognitive reserve moderates the relationship between pain catastrophizing and cognitive function.
Study design
- Observational model
- Family based
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Chronic Pain Patients with Varying Cognitive Reserve | – | Other: No intervention (cross-sectional study)Community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions. |
Who may qualify
- Ages
- 65 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- The study population consists of community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions.
Key inclusion criteria (4 listed)
- Aged 65 to 85 years
- Experiencing chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions
- Able to read, write, and speak the language in which assessments are administered
- Willing and able to provide informed consent
Key exclusion criteria (5 listed)
- Diagnosed with a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease)
- History of significant head injury, stroke, or brain tumor
- Current substance abuse or dependence
- Severe psychiatric illness (e.g., schizophrenia, bipolar disorder)
- Significant sensory or motor impairments that may interfere with the ability to complete assessments
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention (cross-sectional study)This is a cross-sectional study examining the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain; no intervention is being implemented or tested. | Other | Chronic Pain Patients with Varying Cognitive Reserve |
Primary outcome
Association between pain catastrophizing and cognitive function
Time frame: Baseline assessment
he relationship between pain catastrophizing, as measured by the Pain Catastrophizing Scale (PCS), and cognitive function, as measured by the Montreal Cognitive Assessment (MoCA version 7.1).
1 secondary outcome
Moderating effect of cognitive reserve on the association between pain catastrophizing and cognitive function
Time frame: Baseline assessment
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jul 2023.
- Individual participant dataSharing planned: No
Related trials for Chronic Pain
RecruitingObservational study
Quality of Life and Pain After Appendectomy in Children
Chronic Pain, Postoperative, Quality of Life
Recruiting
SENECA - Smart Therapies for Chronic Pain
Chronic Low Back Pain (CLBP)
RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Osteoarthritis, Knee, Chronic Pain
Not yet recruiting
Effects of Expectancy and Mindfulness Instructions on Chronic Pain
Chronic Pain
RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Chronic Pain, Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amal Fawzy, Ph.d study director
Faculty of Physical Therapy, Ahram Canadian University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Pain, run by Ahram Canadian University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mohamed M ElMeligie, Ph.d (+201064442032, mohamed.elmeligie@acu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Association between pain catastrophizing and cognitive function (time frame: Baseline assessment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2023.